Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEOGENOMICS INC Director's Dealing 2025

Jun 4, 2025

32227_dirs_2025-06-03_4e076097-c34f-4692-8401-af2ba514c2b7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2025-06-01

Reporting Person: HANNAH ALISON L. (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-06-01 Common Stock M 12254 Acquired 131023 Direct

Footnotes

F1: Due to clerical error, this amendment to Form 4 is being filed to correct the transaction code in the reported transaction.

F2: As reported in the original Form 4, reflects the release of restricted stock units that were previously reported on a Form 4.